Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24
InChiKey: WKRWUYKLUMMAKG-WYGBAUISSA-L
inhibition of ROCK pathway is believed to contribute to some of the cardiovascular benefits of statin therapy that are independent of lipid lowering (ie
is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment
Negative control for VH 298
03 μg/mL to 0
LY315920(Varespladib) endizoate InChiKey: WKRWUYKLUMMAKG-WYGBAUISSA-LVarespladib, aslo known as LY315920, is a secreted phospholipase A2 (sPLA2) inhibitor (IC50 = 50 750 nM for a range of sPLA2 isoforms). Varespladib reduces atherosclerosis and aneurysm formation in ApoE mice and in guinea pigs. Varespladib significantly reduces the post ACS inflammatory response in those with and without diabetes. Varespladib may be potentially useful for treatment of coronary artery disease. Product information CAS Number: 172732 68
US$ 250.28
US$ 250.28
US$ 250.28